CNBC Television
@CNBCtelevision·3.4M subscribers·157.5K videos
Novo and Lilly are competing to win the GLP-1 pill market
Posted
June 8, 2026
Views
1,280
Likes
15
Comments
2
Engagement
1.33%
June 8, 2026
1,280
15
2
1.33%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:27Now PlayingNovo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare for the next sea change in how patients receive their drugs.
CNBC's Angelica Peebles explains.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
